Trials / Unknown
UnknownNCT02105168
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment in Patients With Lung Cancer or Melanoma
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,200 (estimated)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Lung Cancer and melanoma relapsed frequently whereas its very sensitive to treatment such as chemotherapy or radiotherapy. The purpose of this study is to have a better understanding of why those patients are relapsing using next generation sequencing to identify rare mutations and assessed their predictive value.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood sample | Optional |
| PROCEDURE | Tumorous biopsy | Optional |
| PROCEDURE | Healthy material sample | Optional |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2019-07-01
- Completion
- 2019-07-01
- First posted
- 2014-04-07
- Last updated
- 2016-06-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02105168. Inclusion in this directory is not an endorsement.